DIA’s 1st Workshop on Pre-market Evaluation of Quality and Bioavailability

January 16, 2009

Drug Information Association, Taj Banjara, Hyderabad, India. Feb 5 2009 This workshop will clarify the approval requirements for drugs developed in India for global markets. You will have the opportunity to participate in the exchange of alternative perspectives from industry, academia, and regulatory professionals.

Organized by:			Drug Information Association
Invited Speakers:			Vilayat A. Sayeed, PhD Director, Division of Chemistry III FDA/CDER/OPS/OGD. Dr. Stephanie Parra Manager of Generic Drugs: Quality Division Bureau of Pharmaceutical Sciences TPD Health Canada. Dr. Jan Welink Senior Pharmacokineticist Dutch Evaluation Board, The Netherlands. Shereeni Veerasingham, MBBS, PhD Assessment Officer Division of Biopharmaceutics Evaluation 2 Bureau of Pharmaceutical Sciences Therapeutic Products Directorate.

Deadline for Abstracts:			Feb 5 2009

Registration:			http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=19600&eventType=Meeting
E-mail:			Leena.Amanna@diaindia.org

events